JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Home・Akciju saraksts・Talphera Inc.

Talphera Inc.

Slēgts

0.95 -2.06

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

0.93

Max

0.97

Galvenie mērījumi
By Trading Economics
Darbinieki	13

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+225% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 30. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-22M 39M
Iepriekšējā atvēršanas cena	3.01
Iepriekšējā slēgšanas cena	0.95

Talphera Inc. Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 29. janv. 22:31 UTC

Peļņas

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

2026. g. 29. janv. 22:05 UTC

Peļņas

Stryker Logs Higher 4Q Profit On Sales Gains

2026. g. 29. janv. 21:54 UTC

Peļņas

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

2026. g. 29. janv. 21:36 UTC

Peļņas

Visa 1Q Sales Climb on Strong Holiday Shopping

2026. g. 29. janv. 23:57 UTC

Iegādes, apvienošanās, pārņemšana

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

2026. g. 29. janv. 23:56 UTC

Iegādes, apvienošanās, pārņemšana

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

2026. g. 29. janv. 23:53 UTC

Iegādes, apvienošanās, pārņemšana

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

2026. g. 29. janv. 23:51 UTC

Peļņas

Correction to Intel Earnings Article on Jan. 22 -- WSJ

2026. g. 29. janv. 23:49 UTC

Tirgus saruna

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

2026. g. 29. janv. 23:49 UTC

Tirgus saruna

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

2026. g. 29. janv. 23:47 UTC

Tirgus saruna

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

2026. g. 29. janv. 23:35 UTC

Peļņas

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

2026. g. 29. janv. 23:32 UTC

Tirgus saruna

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

2026. g. 29. janv. 23:32 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 29. janv. 23:15 UTC

Tirgus saruna

Peļņas

Visa Says High Earners Still Lead Spending Growth -- Market Talk

2026. g. 29. janv. 22:27 UTC

Peļņas

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

2026. g. 29. janv. 22:27 UTC

Peļņas

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

2026. g. 29. janv. 22:12 UTC

Peļņas

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

2026. g. 29. janv. 21:55 UTC

Peļņas

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

2026. g. 29. janv. 21:50 UTC

Tirgus saruna

Peļņas

Financial Services Roundup: Market Talk

2026. g. 29. janv. 21:50 UTC

Peļņas

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

2026. g. 29. janv. 21:50 UTC

Tirgus saruna

Peļņas

Health Care Roundup: Market Talk

2026. g. 29. janv. 21:50 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 29. janv. 21:49 UTC

Peļņas

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

2026. g. 29. janv. 21:46 UTC

Peļņas

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

2026. g. 29. janv. 21:36 UTC

Peļņas

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

2026. g. 29. janv. 21:32 UTC

Peļņas

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

2026. g. 29. janv. 21:32 UTC

Peļņas

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

2026. g. 29. janv. 21:30 UTC

Peļņas

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

2026. g. 29. janv. 21:30 UTC

Peļņas

Apple 1Q Mac Rev $8.39B >AAPL

Salīdzinājums

Cenas izmaiņa

Talphera Inc. Prognoze

Cenas mērķis

By TipRanks

225% augšup

Prognoze 12 mēnešiem

Vidējais 3.25 USD 225%

Augstākais 3.5 USD

Zemākais 3 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Talphera Inc. — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

2 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 2 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Talphera Inc. — pēdējo 3 mēnešu laikā.

Finanšu rādītāji

Par Talphera Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.